Insulet reports new data for Omnipod 6 and FCL systems

Insulet has reported results from its STRIVE and EVOLUTION 3 studies, assessing its upcoming Omnipod 6 AID system and a FCL solution for adults with type 2 diabetes. Findings from the STRIVE study indicated improved glycaemic control with Omnipod 6 compared to Omnipod 5. In STRIVE, participants were randomised to use Omnipod 6 at 100mg/dL or Omnipod 5 at 110mg/dL. Credit: Motortion Films / Shutterstock.com. Insulet has reported results from two clinical studies, STRIVE and EVOLUTION 3, assessing its upcoming Omnipod 6 automated insulin delivery (AID) system and a fully closed-loop (FCL) solution for adults with type 2 diabetes (T2D).…

Source: Medical Device Network